1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Enterocolitis, Necrotizing in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (66.67) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, GP; Sylvester, KG | 1 |
| Caplan, MS; Frost, BL | 1 |
| Mahuran, D; Rigat, B; Shehnaz, D; Yeger, H | 1 |
| Caplan, M; Franklin, A; Jilling, T; Lu, J; Pierce, M; Stafforini, DM | 1 |
| Arditi, M; Caplan, MS; Chen, S; Crother, TR; Jilling, T; Karahashi, H; Lu, J; Meng, FJ; Michelsen, KS; Qu, X; Rabizadeh, S; Soliman, A | 1 |
| Hu, XL; Li, XJ; Ning, PR; Peng, L; Song, LY; Zhao, LS | 1 |
| Gilger, M; Harpavat, S; Pammi, M | 1 |
| Huang, LG; Lu, WN; Rong, X; Tao, L; Zhou, W | 1 |
| Denning, PW; Denning, TL; Louis, NA; Mirpuri, J; Myers, L; Parkos, CA; Sotnikov, I; Yarovinsky, F | 1 |
| Ewer, AK | 1 |
| Akisu, M; Baka, M; Huseyinov, A; Kultursay, N | 1 |
| Akisu, M; Baka, M; Huseyinov, A; Kultursay, N; Yalaz, M | 1 |
| Amer, MD; Caplan, MS; Hedlund, E; Rochester, J | 1 |
| Al-Salti, W; Booth, IW; Coney, AM; Ewer, AK; Marshall, JM; Ramani, P | 1 |
| Lu, H; Xue, XD | 1 |
| Fell, JM | 1 |
| Caplan, MS; Jilling, T; Simon, D | 1 |
| Fernandes, CJ; O'Donovan, DJ | 1 |
| Song, CM; Wang, H; Wu, B | 1 |
| Caplan, MS; Frost, BL; Jilling, T | 1 |
| Dzakpasu, P; Kornecki, E; Leblanc, P; Piecuch, S; Rabinowitz, SS; Valencia, G | 1 |
| Amer, M; Caplan, MS; Jilling, T; Kaup, S; Russell, T; Xiao, Y | 1 |
| Akisu, M; Baka, M; Hüsseyinov, A; Küllahçioğlu Girgin, F; Kültürsay, N | 1 |
| Caplan, MS; Jilling, T | 1 |
10 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Enterocolitis, Necrotizing
| Article | Year |
|---|---|
Biomarker Discovery and Utility in Necrotizing Enterocolitis.
Topics: Alpha-Globulins; Biomarkers; Blood Cell Count; Breath Tests; C-Reactive Protein; Claudins; Complement C5a; Cytokines; Early Diagnosis; Enterocolitis, Necrotizing; Epidermal Growth Factor; Fatty Acid-Binding Proteins; Gastrointestinal Microbiome; Genomics; Humans; Hydrogen; Infant, Newborn; Infant, Premature; Leukocyte L1 Antigen Complex; Metabolomics; Platelet Activating Factor; Procalcitonin; Prognosis; Proteomics; Risk Assessment; S100A12 Protein; Sensitivity and Specificity; Serum Albumin, Human; Serum Amyloid A Protein; Spectroscopy, Near-Infrared; Trefoil Factor-3; Ultrasonography; Volatile Organic Compounds | 2019 |
Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics.
Topics: Biomarkers; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Platelet Activating Factor; Probiotics; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Novel treatments for NEC: keeping IBD in mind.
Topics: Enterocolitis, Necrotizing; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intestinal Mucosa; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor | 2012 |
Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Inflammation Mediators; Intestinal Mucosa; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prognosis; Rats; Risk Assessment; Swine | 2002 |
[Platelet-activating factor and neonatal necrotizing enterocolitis].
Topics: Animals; Diet; Enterocolitis, Necrotizing; Humans; Infant, Newborn; NF-kappa B; Platelet Activating Factor; Risk Factors; Tumor Necrosis Factor-alpha | 2004 |
Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis.
Topics: Colitis; Enterocolitis, Necrotizing; Epidermal Growth Factor; Gastrointestinal Tract; Humans; Infant, Newborn; Platelet Activating Factor | 2005 |
The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis.
Topics: Bacteria; Bacterial Infections; Cytokines; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Platelet Activating Factor; Toll-Like Receptors | 2005 |
Platelet transfusions in infants with necrotizing enterocolitis.
Topics: Enterocolitis, Necrotizing; Humans; Infant, Newborn; Platelet Activating Factor; Platelet Transfusion; Practice Guidelines as Topic; Thrombocytopenia | 2006 |
The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis.
Topics: Cytokines; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Platelet Activating Factor; Signal Transduction; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2008 |
The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis.
Topics: Animals; Enterocolitis; Enterocolitis, Necrotizing; Fatty Acids, Unsaturated; Humans; Infant; Intestines; Platelet Activating Factor | 2001 |
14 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Enterocolitis, Necrotizing
| Article | Year |
|---|---|
GM2 activator protein inhibits platelet activating factor signaling in rats.
Topics: Animals; Disease Models, Animal; Enterocolitis, Necrotizing; G(M2) Activator Protein; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction | 2009 |
Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Analysis of Variance; Animals; Apoptosis; Chemokine CXCL1; Cytokines; Enterocolitis, Necrotizing; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Phospholipases A2, Secretory; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis.
Topics: Animals; Cell Line; Enterocolitis, Necrotizing; Humans; Intestinal Mucosa; Platelet Activating Factor; Rats; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2010 |
[Expression of platelet-activating factor in necrotizing enterocolitis and its clinical significance].
Topics: Enterocolitis, Necrotizing; Female; Humans; Immunohistochemistry; Infant, Newborn; Intestinal Mucosa; Male; Platelet Activating Factor | 2011 |
[Effects of glycomacropeptide on damage to intestinal tissue and apoptosis of intestinal epithelial cells in neonatal rats with necrotizing enterocolitis].
Topics: Animals; Animals, Newborn; Apoptosis; Caseins; Cold Temperature; Enterocolitis, Necrotizing; Epithelial Cells; Female; Hypoxia; Interleukin-1beta; Intestinal Mucosa; Intestines; Male; Peptide Fragments; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha | 2012 |
Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit.
Topics: Animals; Chemokine CXCL2; Colon; Cytokines; Enterocolitis, Necrotizing; Gene Expression Regulation, Developmental; Humans; Inflammation Mediators; Interleukin-10; Interleukin-10 Receptor beta Subunit; Intestinal Mucosa; Intestines; Lacticaseibacillus rhamnosus; Lipopolysaccharides; Mice; Phosphorylation; Platelet Activating Factor; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Tumor Necrosis Factor-alpha; Weaning | 2012 |
The role of dietary supplementation with L-glutamine in inflammatory mediator release and intestinal injury in hypoxia/reoxygenation-induced experimental necrotizing enterocolitis.
Topics: Administration, Oral; Animals; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Necrotizing; Glutamine; Hypoxia; Intestinal Mucosa; Intestines; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Random Allocation; Tumor Necrosis Factor-alpha | 2003 |
Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice.
Topics: Animals; Biological Therapy; Enterocolitis, Necrotizing; Hypoxia; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Oxygen; Platelet Activating Factor; Saccharomyces; Tumor Necrosis Factor-alpha | 2003 |
Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Enteral Nutrition; Enterocolitis, Necrotizing; Feces; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male; Platelet Activating Factor; Prospective Studies | 2004 |
The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis.
Topics: Animals; Animals, Newborn; Azepines; Blood Gas Analysis; Blood Pressure; Enterocolitis, Necrotizing; Hypoxia; Intestinal Mucosa; Lipopolysaccharides; Mesenteric Arteries; Models, Animal; Platelet Activating Factor; Regional Blood Flow; Swine; Triazoles; Vascular Resistance | 2004 |
[Effects of bificobacterium longum on neonatal rat model of necrotizing enterocolitis and roles of platelet-activating factor and tumor necrosis factor-alpha].
Topics: Animals; Animals, Newborn; Disease Models, Animal; Enterocolitis, Necrotizing; Female; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sulfalene; Tumor Necrosis Factor-alpha | 2007 |
Platelet-activating factor in infants at risk for necrotizing enterocolitis.
Topics: Case-Control Studies; Disease Progression; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Platelet Activating Factor; Predictive Value of Tests; Risk Factors; Severity of Illness Index | 2001 |
Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model.
Topics: Animals; Animals, Newborn; Base Sequence; DNA Primers; Enteritis; Enterocolitis, Necrotizing; Fatty Acids, Unsaturated; Female; Gene Expression Regulation, Enzymologic; In Situ Nick-End Labeling; Intestines; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phospholipases A; Platelet Activating Factor; Pregnancy; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Enterocolitis, Necrotizing; Erythropoietin; Female; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Platelet Activating Factor; Probability; Rats; Rats, Wistar; Recombinant Proteins; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |